BRCA2 and familial hypercholesterolemia: It has been suggested for several diseases that extreme PGS risk confers a similar magnitude of increased risk as the presence of Mendelian pathogenic variants (for example, familial hypercholesterolemia for coronary artery disease, and BRCA1 or BRCA2 for breast cancer12,19,20).